EquityZen Growth Technology Fund LLC - Series 1878
Raised
$287K
Investors
12
Min Invest
$5,016
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1878 is a Delaware pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett on May 2, 2024. The fund raised $287K from 12 investors under Rule 506(b) and 3(c)(1) exemptions, with a $5K minimum investment. It is part of the EquityZen platform, which operates over 150 related EDGAR entities focused on private equity technology investments.
This offering fits the typical EquityZen series fund structure: a sub-$1M raise under 506(b) with 3(c)(1) registration exemption, allowing up to 100 beneficial owners. The $5K minimum is accessible compared to traditional private equity funds, and the 12-investor count suggests moderate retail participation consistent with platform-based secondary market access vehicles.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
